117 related articles for article (PubMed ID: 10353747)
1. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.
Shimoyama S; Yamasaki K; Kawahara M; Kaminishi M
Clin Cancer Res; 1999 May; 5(5):1125-30. PubMed ID: 10353747
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of the selected, late phase of angiogenesis factors' concentration in colorectal cancer patients].
Wieloch M; Swiatkowska M; Libiszewski M; Hedayati M; Drozda R; Kołomecki K
Pol Merkur Lekarski; 2009 Dec; 27(162):466-9. PubMed ID: 20120708
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
7. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer.
Basoglu M; Yildirgan MI; Taysi S; Yilmaz I; Kiziltunc A; Balik AA; Celebi F; Atamanalp SS
J Surg Oncol; 2003 Jul; 83(3):180-4. PubMed ID: 12827689
[TBL] [Abstract][Full Text] [Related]
8. Gastrin levels in patients with colorectal cancer.
Fontanesi BV; Boris B; Delcio M; Manoukian FN
Hepatogastroenterology; 1997; 44(16):1082-4. PubMed ID: 9261603
[TBL] [Abstract][Full Text] [Related]
9. Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer.
Ramcharan SK; Lip GY; Stonelake PS; Blann AD
Eur J Clin Invest; 2013 Aug; 43(8):801-8. PubMed ID: 23683169
[TBL] [Abstract][Full Text] [Related]
10. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness.
Shimoyama S; Gansauge F; Gansauge S; Negri G; Oohara T; Beger HG
Cancer Res; 1996 Jun; 56(12):2703-6. PubMed ID: 8665497
[TBL] [Abstract][Full Text] [Related]
11. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.
Kumar H; Heer K; Lee PW; Duthie GS; MacDonald AW; Greenman J; Kerin MJ; Monson JR
Clin Cancer Res; 1998 May; 4(5):1279-85. PubMed ID: 9607588
[TBL] [Abstract][Full Text] [Related]
13. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic protein expression in advanced epithelial ovarian cancer.
Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
[TBL] [Abstract][Full Text] [Related]
15. Increased angiogenin expression in gastric cancer correlated with cancer progression.
Shimoyama S; Kaminishi M
J Cancer Res Clin Oncol; 2000 Aug; 126(8):468-74. PubMed ID: 10961390
[TBL] [Abstract][Full Text] [Related]
16. Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection.
Shantha Kumara HM; Kirman I; Feingold D; Cekic V; Nasar A; Arnell T; Balik E; Hoffman A; Baxter R; Conte S; Whelan RL
Eur J Surg Oncol; 2009 Mar; 35(3):295-301. PubMed ID: 18782657
[TBL] [Abstract][Full Text] [Related]
17. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
[TBL] [Abstract][Full Text] [Related]
19. Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis.
Haraguchi M; Komuta K; Akashi A; Matsuzaki S; Furui J; Kanematsu T
Oncol Rep; 2002; 9(1):159-65. PubMed ID: 11748475
[TBL] [Abstract][Full Text] [Related]
20. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]